Clicky

Saturday, October 31, 2026

Companies

Public company updates

UFP Industries amends credit agreement, plans acquisition

UFP Industries, Inc. extends credit facility maturity to 2031 and announces acquisition of Apache Products, enhancing its market position.

SITIME Corp board sees resignation of director Katherine Schuelke

SITIME Corp announces the resignation of director Katherine E. Schuelke, reducing its board size to eight members. The change is amicable and reflects stability.

Laser Photonics Corp Receives Nasdaq Delisting Notification

Laser Photonics Corp has been notified by Nasdaq about non-compliance with minimum bid price requirements, facing potential delisting by April 2027.

LQR House Inc. Chief Marketing Officer Resigns

LQR House Inc. announces the resignation of Chief Marketing Officer Jaclyn Hoffman, impacting its marketing strategies in the competitive beverage industry.

Faraday Future sells robotics business to FFR for $200 million

Faraday Future has finalized the sale of its robotics business to FFR for $200 million, marking a strategic shift in its operations.

Peoples Bancorp Inc. Reports Q3 Results and Financial Update

Peoples Bancorp Inc. shares its financial results for Q3 2026, highlighting key performance metrics and insights into its operations.

Marten Transport reports Q3 2026 financial results

Marten Transport Ltd. announces its Q3 2026 financial results, providing insights into its operational performance and the trucking industry.

Cedar Realty Trust Declares Dividends on Preferred Stocks

Cedar Realty Trust announces cash dividends for its preferred stocks, reflecting financial stability and confidence in the real estate investment trust sector.

Vivid Seats announces leadership changes in SEC filing

Vivid Seats Inc. reveals leadership changes, including a board member resignation and new executive appointments, impacting its strategic direction.

Urban One amends debt agreement to enhance asset flexibility

Urban One, Inc. has amended its debt agreement to allow for greater asset management flexibility, receiving majority consent from noteholders.

Nixxy, Inc. appoints Robert Reda to Board of Directors

Nixxy, Inc. announces the appointment of Robert Reda to its Board of Directors, following the resignation of Lillian Mbeki, effective immediately.

FedEx announces executive leadership changes amid challenges

FedEx Corp reveals leadership changes that could impact its strategy and the air courier services industry amid ongoing logistics challenges.

Civista Bancshares appoints Jeremy Normington-Slay to Board

Civista Bancshares has appointed Jeremy Normington-Slay to its Board of Directors, enhancing its leadership in the state commercial banking sector.

Aterian secures $1 million unsecured promissory note

Aterian, Inc. has entered into a $1 million unsecured promissory note to bolster its financial position and support operational needs.

Climb Bio Reports Phase 1 Data for CLYM116 at ASN Kidney Week

Climb Bio, Inc. shares positive Phase 1 data for CLYM116, an anti-APRIL monoclonal antibody for IgA nephropathy, during ASN Kidney Week 2026.

AAR Corp Amends Revolving Credit Facility to $1.375 Billion

AAR Corp has amended its revolving credit facility to $1.375 billion, enhancing financial flexibility amid ongoing acquisition efforts.

Mobility Global grants new stock awards to executives

Mobility Global Inc. announces restricted stock unit awards for executives, highlighting a strategic focus on leadership incentives in the business services sector.

Gyre Therapeutics announces new employment agreements for CEO, CFO

Gyre Therapeutics, Inc. secures leadership with new agreements for CEO Ying Luo and CFO Thomas Eastling, emphasizing stability in the pharmaceutical sector.

Edgemode, Inc. Secures $159,600 Through Convertible Note

Edgemode, Inc. has secured $159,600 by issuing a convertible promissory note, aimed at enhancing its working capital in the home health care services sector.

MacroGenics Reports Positive Interim Results for MGC026

MacroGenics, Inc. shares promising interim results for its cancer treatment MGC026, potentially advancing its position in the pharmaceutical industry.

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →